http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1307555-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
filingDate | 2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf394e5db55c9e00d2083d19f4ae9f0 |
publicationDate | 2003-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1307555-A2 |
titleOfInvention | 18610, a human transient receptor and uses thereof |
abstract | The invention provides isolated nucleic acids molecules, designated TR-1 nucleic acid molecules, which encode novel transient receptor potential channel molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TR-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a TR-1 gene has been introduced or disrupted. The invention still further provides isolated TR-1 polypeptides, fusion polypeptides, antigenic peptides and anti-TR-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
priorityDate | 2000-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 827.